Get started
Author

Carolina Maria Sassu

Observed names: C. M. Sassu, C. Sassu, C.M. Sassu, Carolina M. Sassu, Carolina Sassu, Carolina Maria Sassu, Sassu CM
ORCID: 0000-0002-1702-5859
Observed ORCID: 0000-0002-1702-5859
OpenAlex ID: A5044516925
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments
2021 · Claudia Marchetti, Francesca De Felice, et al. · Seminars in Cancer Biology · 138
Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
2018 · C. Marchetti, F. De Felice, et al. · Critical Reviews in Oncology/Hematology · 100
Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case–control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis
2015 · Nadia Recine, Ettore Palma, et al. · Archives of Gynecology and Obstetrics · 88
Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA mutational status
2019 · Federica Tomao, Erlisa Bardhi, et al. · Cancer Treatment Reviews · 79
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
2020 · Innocenza Palaia, Federica Tomao, et al. · OncoTargets and Therapy · 76
PDF
Rucaparib: An emerging parp inhibitor for treatment of recurrent ovarian cancer
2018 · Angela Musella, Erlisa Bardhi, et al. · Cancer Treatment Reviews · 60
Fertility preservation in ovarian tumours
2018 · Federica Tomao, Anna Di Pinto, et al. · ecancermedicalscience · 28
PDF
Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know
2017 · F. De Felice, C. Marchetti, et al. · Cancer Treatment Reviews · 24
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
2025 · C. Marchetti, A. Fagotti, et al. · ESMO Open · 19
PDF
Fertility-sparing surgery for women with stage I cervical cancer of 4 cm or larger: a systematic review
2021 · Violante Di Donato, Giuseppe Caruso, et al. · Journal of Gynecologic Oncology · 19
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients
2022 · Claudia Marchetti, Beyhan Ataseven, et al. · International Journal of Gynecological Cancer · 16
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
2021 · Carolina Maria Sassu, Innocenza Palaia, et al. · International Journal of Molecular Sciences · 16
PDF
The EOLO (End-of-Life Ovarian Cancer) Study: Approach to Ovarian Cancer Patients at the End of Life
2019 · Innocenza Palaia, Federica Tomao, et al. · Oncology · 12
The role of Chemotherapy Response Score (CRS) in the decision making process for patients with advanced high grade serous ovarian cancer undergoing neoadjuvant chemotherapy.
2023 · Claudia Marchetti, Raffaella Ergasti, et al. · Journal of Clinical Oncology · 10
PDF
The puzzle of gynecologic neuroendocrine carcinomas: State of the art and future directions
2021 · Giuseppe Caruso, Carolina Maria Sassu, et al. · Critical Reviews in Oncology/Hematology · 10
Focus on Trabectedin in Ovarian Cancer: What Do We Still Need to Know?
2024 · Serena Maria Boccia, Carolina Maria Sassu, et al. · Drug Design Development and Therapy · 7
PDF
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery
2025 · Claudia Marchetti, Raffaella Ergasti, et al. · Gynecologic Oncology · 6
PDF
Effects of niraparib dose reduction on short-term outcomes in ovarian cancer patients
2024 · Matteo Bruno, Adriana Ionelia Apostol, et al. · International Journal of Gynecological Cancer · 6
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status
2024 · Claudia Marchetti, Beyhan Ataseven, et al. · Gynecologic Oncology · 6
PDF
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
2020 · Palaia I, Tomao F, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 6
Post-conization cervical stenosis treated with silicone catheter in microinvasive cervical cancer patient
2020 · Angela Musella, Giusi Santangelo, et al. · International Journal of Surgery Case Reports · 6
PDF
Relacorilant in recurrent ovarian cancer: clinical evidence and future perspectives
2024 · Elena Giudice, Vanda Salutari, et al. · Expert Review of Anticancer Therapy · 5
ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome
2026 · Claudia Marchetti, Murat Gultekin, et al. · European Journal of Cancer · 4
Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study
2025 · C. Marchetti, A. Fagotti, et al. · ESMO Open · 4
PDF
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?
2024 · Carolina Maria Sassu, Claudia Marchetti, et al. · International Journal of Gynecological Cancer · 4
Works count: 89
Citation count: 778
H-index: 12
I10-index: 14
Year
Topic
Type